| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |